Home › Companies › IRONWOOD PHARMACEUTICALS INC. › 2023-2024
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and IRONWOOD PHARMACEUTICALS INC.’s Form 8-K, filed June 21, 2024 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of June 18, 2024: 11 items on IRONWOOD PHARMACEUTICALS INC.’s Form 8-K, filed June 21, 2024: 9 elected · 2 approved.
No notable dissent.
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Proxy season: 2023-2024 2024-2025 2025-2026
Activist investors: Sarissa Capital (13D, 5.8%, as of March 19, 2026)
Explore IRONWOOD PHARMACEUTICALS INC. in the interactive database Compare manager voting policies
These tallies are IRONWOOD PHARMACEUTICALS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 21, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Mark Currie, Ph.D. | 130,019,704 | -- | -- | 5,472,128 | 7,708,364 | 96% | Elected | — |
| Elect Director: Alexander Denner, Ph.D. | 125,450,072 | -- | -- | 10,041,760 | 7,708,364 | 93% | Elected | — |
| Elect Director: Andrew Dreyfus | 129,704,783 | -- | -- | 5,787,049 | 7,708,364 | 96% | Elected | — |
| Elect Director: Jon Duane | 127,436,834 | -- | -- | 8,054,998 | 7,708,364 | 94% | Elected | — |
| Elect Director: Marla Kessler | 130,081,722 | -- | -- | 5,410,110 | 7,708,364 | 96% | Elected | — |
| Elect Director: Thomas McCourt | 133,639,699 | -- | -- | 1,852,133 | 7,708,364 | 99% | Elected | — |
| Elect Director: Julie McHugh | 124,822,215 | -- | -- | 10,669,617 | 7,708,364 | 92% | Elected | — |
| Elect Director: Catherine Moukheibir | 129,803,799 | -- | -- | 5,688,033 | 7,708,364 | 96% | Elected | — |
| Elect Director: Jay Shepard | 133,672,033 | -- | -- | 1,819,799 | 7,708,364 | 99% | Elected | — |
| 2. On a non-binding advisory basis, the compensation paid to the Company's named executive officers, as disclosed in the Company's proxy statement for the Annual Meeting | 127,439,687 | 7,953,508 | 98,637 | -- | 7,708,364 | 94% | Approved | — |
| 3. The selection of Ernst & Young LLP as the Company's independent registered public accounting firm for 2024 | 136,781,986 | 6,305,538 | 112,672 | -- | -- | 96% | Approved | — |
This meeting is also recorded here as June 19, 2024; both records come from the same filing, so the date should be checked against it.
Source: IRONWOOD PHARMACEUTICALS INC., Form 8-K, filed with the SEC on June 21, 2024 — read the filing on EDGAR.
See voting trends for Health Care companies, 2023-2024: shareholder support by sector and by company size.
286 asset managers disclosed a vote on at least one IRONWOOD PHARMACEUTICALS INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 4 wordings of this item as funds reported it.
93% Majority: yes · of votes cast
Prior year: 96.9% for (June 20, 2023 meeting) ▼ 4.3 pts
Description as filed by funds: Election of Directors. To elect nine director nominees numbered 01 through 09 to serve for a one-year term extending until the 2025 annual meeting of stockholders and their successors are duly elected and qualified: Alexander Denner, Ph.D.
IRONWOOD PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Alexander Denner, Ph.D.”): 125,450,072 for, 10,041,760 withheld, per its Form 8-K filed June 21, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The stockholders elected nine director nominees, each to serve on the board of directors of the Company for a one-year term extending until the 2024 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified, or until his or her death, resignation or removal, based …”
Support: 93% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 90 asset managers below reported 69,700,287 for, 2,333,295 withheld, 7,297 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 19,802,874 | 0 | 0 | 0 | For |
| BlackRock | 16,293,964 | 0 | 0 | 0 | For |
| State Street | 9,849,151 | 0 | 0 | 2,569 | For |
| Pacer Funds Trust | 7,393,012 | 0 | 0 | 0 | For |
| Fidelity | 3,523,928 | 0 | 0 | 0 | For |
| TIAA | 0 | 0 | 0 | 1,846,558 | Withhold |
| Charles Schwab | 1,362,879 | 0 | 0 | 0 | For |
| GLENMEDE FUND INC | 1,066,522 | 0 | 0 | 0 | For |
| FIRST EAGLE FUNDS | 932,893 | 0 | 0 | 0 | For |
| Brown Capital Management Mutual Funds | 770,390 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 610,957 | 0 | 0 | 0 | For |
| Royce | 578,312 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 480,330 | 0 | 0 | 0 | For |
| NORTHERN LIGHTS FUND TRUST II | 400,000 | 0 | 0 | 0 | For |
| Principal | 378,739 | 0 | 0 | 0 | For |
| Equitable | 357,417 | 0 | 0 | 0 | For |
| Invesco | 352,644 | 0 | 0 | 0 | For |
| Nationwide | 338,218 | 0 | 0 | 12,500 | For |
| FINANCIAL INVESTORS TRUST | 339,705 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 300,000 | Withhold |
| Jackson National | 297,949 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 295,089 | 0 | 0 | 0 | For |
| SEI | 281,994 | 0 | 0 | 0 | For |
| Putnam | 261,367 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 258,397 | 0 | 0 | 0 | For |
Showing the 25 largest of 90 asset managers. All 90 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Prior year: 98.4% for (June 20, 2023 meeting) ▼ 2.7 pts
Description as filed by funds: Election of Directors. To elect nine director nominees numbered 01 through 09 to serve for a one-year term extending until the 2025 annual meeting of stockholders and their successors are duly elected and qualified: Andrew Dreyfus
IRONWOOD PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Andrew Dreyfus”): 129,704,783 for, 5,787,049 withheld, per its Form 8-K filed June 21, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The stockholders elected nine director nominees, each to serve on the board of directors of the Company for a one-year term extending until the 2024 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified, or until his or her death, resignation or removal, based …”
Support: 96% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 90 asset managers below reported 71,972,072 for, 61,510 withheld, 7,297 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 19,802,874 | 0 | 0 | 0 | For |
| BlackRock | 16,293,964 | 0 | 0 | 0 | For |
| State Street | 9,850,449 | 0 | 0 | 1,271 | For |
| Pacer Funds Trust | 7,393,012 | 0 | 0 | 0 | For |
| Fidelity | 3,523,928 | 0 | 0 | 0 | For |
| TIAA | 1,846,558 | 0 | 0 | 0 | For |
| Charles Schwab | 1,362,879 | 0 | 0 | 0 | For |
| GLENMEDE FUND INC | 1,066,522 | 0 | 0 | 0 | For |
| FIRST EAGLE FUNDS | 932,893 | 0 | 0 | 0 | For |
| Brown Capital Management Mutual Funds | 770,390 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 610,957 | 0 | 0 | 0 | For |
| Royce | 578,312 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 480,330 | 0 | 0 | 0 | For |
| NORTHERN LIGHTS FUND TRUST II | 400,000 | 0 | 0 | 0 | For |
| Principal | 378,739 | 0 | 0 | 0 | For |
| Equitable | 357,417 | 0 | 0 | 0 | For |
| Invesco | 352,644 | 0 | 0 | 0 | For |
| Nationwide | 350,718 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 339,705 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 300,000 | 0 | 0 | 0 | For |
| Jackson National | 297,949 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 295,089 | 0 | 0 | 0 | For |
| SEI | 281,994 | 0 | 0 | 0 | For |
| Putnam | 261,367 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 258,397 | 0 | 0 | 0 | For |
Showing the 25 largest of 90 asset managers. All 90 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Prior year: 97.8% for (June 20, 2023 meeting) ▼ 2.0 pts
Description as filed by funds: Election of Directors. To elect nine director nominees numbered 01 through 09 to serve for a one-year term extending until the 2025 annual meeting of stockholders and their successors are duly elected and qualified: Catherine Moukheibir
IRONWOOD PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Catherine Moukheibir”): 129,803,799 for, 5,688,033 withheld, per its Form 8-K filed June 21, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The stockholders elected nine director nominees, each to serve on the board of directors of the Company for a one-year term extending until the 2024 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified, or until his or her death, resignation or removal, based …”
Support: 96% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 90 asset managers below reported 71,928,401 for, 108,463 withheld, 4,015 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 19,802,874 | 0 | 0 | 0 | For |
| BlackRock | 16,293,964 | 0 | 0 | 0 | For |
| State Street | 9,850,449 | 0 | 0 | 1,271 | For |
| Pacer Funds Trust | 7,393,012 | 0 | 0 | 0 | For |
| Fidelity | 3,523,928 | 0 | 0 | 0 | For |
| TIAA | 1,846,558 | 0 | 0 | 0 | For |
| Charles Schwab | 1,362,879 | 0 | 0 | 0 | For |
| GLENMEDE FUND INC | 1,066,522 | 0 | 0 | 0 | For |
| FIRST EAGLE FUNDS | 932,893 | 0 | 0 | 0 | For |
| Brown Capital Management Mutual Funds | 770,390 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 610,957 | 0 | 0 | 0 | For |
| Royce | 578,312 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 480,330 | 0 | 0 | 0 | For |
| NORTHERN LIGHTS FUND TRUST II | 400,000 | 0 | 0 | 0 | For |
| Principal | 378,269 | 0 | 0 | 470 | For |
| Equitable | 357,417 | 0 | 0 | 0 | For |
| Invesco | 352,644 | 0 | 0 | 0 | For |
| Nationwide | 350,718 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 339,705 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 300,000 | 0 | 0 | 0 | For |
| Jackson National | 297,949 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 295,089 | 0 | 0 | 0 | For |
| SEI | 281,994 | 0 | 0 | 0 | For |
| Putnam | 261,367 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 258,397 | 0 | 0 | 0 | For |
Showing the 25 largest of 90 asset managers. All 90 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Prior year: 98.8% for (June 20, 2023 meeting) ▼ 0.1 pts
Description as filed by funds: Election of Directors. To elect nine director nominees numbered 01 through 09 to serve for a one-year term extending until the 2025 annual meeting of stockholders and their successors are duly elected and qualified: Jay Shepard
IRONWOOD PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Jay Shepard”): 133,672,033 for, 1,819,799 withheld, per its Form 8-K filed June 21, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The stockholders elected nine director nominees, each to serve on the board of directors of the Company for a one-year term extending until the 2024 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified, or until his or her death, resignation or removal, based …”
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 90 asset managers below reported 71,975,354 for, 61,510 withheld, 4,015 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 19,802,874 | 0 | 0 | 0 | For |
| BlackRock | 16,293,964 | 0 | 0 | 0 | For |
| State Street | 9,850,449 | 0 | 0 | 1,271 | For |
| Pacer Funds Trust | 7,393,012 | 0 | 0 | 0 | For |
| Fidelity | 3,523,928 | 0 | 0 | 0 | For |
| TIAA | 1,846,558 | 0 | 0 | 0 | For |
| Charles Schwab | 1,362,879 | 0 | 0 | 0 | For |
| GLENMEDE FUND INC | 1,066,522 | 0 | 0 | 0 | For |
| FIRST EAGLE FUNDS | 932,893 | 0 | 0 | 0 | For |
| Brown Capital Management Mutual Funds | 770,390 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 610,957 | 0 | 0 | 0 | For |
| Royce | 578,312 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 480,330 | 0 | 0 | 0 | For |
| NORTHERN LIGHTS FUND TRUST II | 400,000 | 0 | 0 | 0 | For |
| Principal | 378,739 | 0 | 0 | 0 | For |
| Equitable | 357,417 | 0 | 0 | 0 | For |
| Invesco | 352,644 | 0 | 0 | 0 | For |
| Nationwide | 350,718 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 339,705 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 300,000 | 0 | 0 | 0 | For |
| Jackson National | 297,949 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 295,089 | 0 | 0 | 0 | For |
| SEI | 281,994 | 0 | 0 | 0 | For |
| Putnam | 261,367 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 258,397 | 0 | 0 | 0 | For |
Showing the 25 largest of 90 asset managers. All 90 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
Prior year: 98.0% for (June 20, 2023 meeting) ▼ 4.0 pts
Description as filed by funds: Election of Directors. To elect nine director nominees numbered 01 through 09 to serve for a one-year term extending until the 2025 annual meeting of stockholders and their successors are duly elected and qualified: Jon Duane
IRONWOOD PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Jon Duane”): 127,436,834 for, 8,054,998 withheld, per its Form 8-K filed June 21, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The stockholders elected nine director nominees, each to serve on the board of directors of the Company for a one-year term extending until the 2024 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified, or until his or her death, resignation or removal, based …”
Support: 94% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 90 asset managers below reported 71,646,693 for, 390,171 withheld, 4,015 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 19,802,874 | 0 | 0 | 0 | For |
| BlackRock | 16,293,964 | 0 | 0 | 0 | For |
| State Street | 9,849,151 | 0 | 0 | 2,569 | For |
| Pacer Funds Trust | 7,393,012 | 0 | 0 | 0 | For |
| Fidelity | 3,523,928 | 0 | 0 | 0 | For |
| TIAA | 1,846,558 | 0 | 0 | 0 | For |
| Charles Schwab | 1,362,879 | 0 | 0 | 0 | For |
| GLENMEDE FUND INC | 1,066,522 | 0 | 0 | 0 | For |
| FIRST EAGLE FUNDS | 932,893 | 0 | 0 | 0 | For |
| Brown Capital Management Mutual Funds | 770,390 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 610,957 | 0 | 0 | 0 | For |
| Royce | 578,312 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 480,330 | 0 | 0 | 0 | For |
| NORTHERN LIGHTS FUND TRUST II | 400,000 | 0 | 0 | 0 | For |
| Principal | 378,739 | 0 | 0 | 0 | For |
| Equitable | 357,417 | 0 | 0 | 0 | For |
| Invesco | 352,644 | 0 | 0 | 0 | For |
| Nationwide | 338,218 | 0 | 0 | 12,500 | For |
| FINANCIAL INVESTORS TRUST | 339,705 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 300,000 | Withhold |
| Jackson National | 297,949 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 295,089 | 0 | 0 | 0 | For |
| SEI | 281,994 | 0 | 0 | 0 | For |
| Putnam | 261,367 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 258,397 | 0 | 0 | 0 | For |
Showing the 25 largest of 90 asset managers. All 90 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
92% Majority: yes · of votes cast
Prior year: 97.6% for (June 20, 2023 meeting) ▼ 5.5 pts
Description as filed by funds: Election of Directors. To elect nine director nominees numbered 01 through 09 to serve for a one-year term extending until the 2025 annual meeting of stockholders and their successors are duly elected and qualified: Julie McHugh
IRONWOOD PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Julie McHugh”): 124,822,215 for, 10,669,617 withheld, per its Form 8-K filed June 21, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The stockholders elected nine director nominees, each to serve on the board of directors of the Company for a one-year term extending until the 2024 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified, or until his or her death, resignation or removal, based …”
Support: 92% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 90 asset managers below reported 71,646,693 for, 390,171 withheld, 4,015 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 19,802,874 | 0 | 0 | 0 | For |
| BlackRock | 16,293,964 | 0 | 0 | 0 | For |
| State Street | 9,849,151 | 0 | 0 | 2,569 | For |
| Pacer Funds Trust | 7,393,012 | 0 | 0 | 0 | For |
| Fidelity | 3,523,928 | 0 | 0 | 0 | For |
| TIAA | 1,846,558 | 0 | 0 | 0 | For |
| Charles Schwab | 1,362,879 | 0 | 0 | 0 | For |
| GLENMEDE FUND INC | 1,066,522 | 0 | 0 | 0 | For |
| FIRST EAGLE FUNDS | 932,893 | 0 | 0 | 0 | For |
| Brown Capital Management Mutual Funds | 770,390 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 610,957 | 0 | 0 | 0 | For |
| Royce | 578,312 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 480,330 | 0 | 0 | 0 | For |
| NORTHERN LIGHTS FUND TRUST II | 400,000 | 0 | 0 | 0 | For |
| Principal | 378,739 | 0 | 0 | 0 | For |
| Equitable | 357,417 | 0 | 0 | 0 | For |
| Invesco | 352,644 | 0 | 0 | 0 | For |
| Nationwide | 338,218 | 0 | 0 | 12,500 | For |
| FINANCIAL INVESTORS TRUST | 339,705 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 300,000 | Withhold |
| Jackson National | 297,949 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 295,089 | 0 | 0 | 0 | For |
| SEI | 281,994 | 0 | 0 | 0 | For |
| Putnam | 261,367 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 258,397 | 0 | 0 | 0 | For |
Showing the 25 largest of 90 asset managers. All 90 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Prior year: 44.2% for (June 20, 2023 meeting) ▲ 51.8 pts
Description as filed by funds: Election of Directors. To elect nine director nominees numbered 01 through 09 to serve for a one-year term extending until the 2025 annual meeting of stockholders and their successors are duly elected and qualified: Mark Currie, Ph.D.
IRONWOOD PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Mark Currie, Ph.D.”): 130,019,704 for, 5,472,128 withheld, per its Form 8-K filed June 21, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The stockholders elected nine director nominees, each to serve on the board of directors of the Company for a one-year term extending until the 2024 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified, or until his or her death, resignation or removal, based …”
Support: 96% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 90 asset managers below reported 71,975,354 for, 61,510 withheld, 4,015 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 19,802,874 | 0 | 0 | 0 | For |
| BlackRock | 16,293,964 | 0 | 0 | 0 | For |
| State Street | 9,850,449 | 0 | 0 | 1,271 | For |
| Pacer Funds Trust | 7,393,012 | 0 | 0 | 0 | For |
| Fidelity | 3,523,928 | 0 | 0 | 0 | For |
| TIAA | 1,846,558 | 0 | 0 | 0 | For |
| Charles Schwab | 1,362,879 | 0 | 0 | 0 | For |
| GLENMEDE FUND INC | 1,066,522 | 0 | 0 | 0 | For |
| FIRST EAGLE FUNDS | 932,893 | 0 | 0 | 0 | For |
| Brown Capital Management Mutual Funds | 770,390 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 610,957 | 0 | 0 | 0 | For |
| Royce | 578,312 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 480,330 | 0 | 0 | 0 | For |
| NORTHERN LIGHTS FUND TRUST II | 400,000 | 0 | 0 | 0 | For |
| Principal | 378,739 | 0 | 0 | 0 | For |
| Equitable | 357,417 | 0 | 0 | 0 | For |
| Invesco | 352,644 | 0 | 0 | 0 | For |
| Nationwide | 350,718 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 339,705 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 300,000 | 0 | 0 | 0 | For |
| Jackson National | 297,949 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 295,089 | 0 | 0 | 0 | For |
| SEI | 281,994 | 0 | 0 | 0 | For |
| Putnam | 261,367 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 258,397 | 0 | 0 | 0 | For |
Showing the 25 largest of 90 asset managers. All 90 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Prior year: 98.8% for (June 20, 2023 meeting) ▼ 2.8 pts
Description as filed by funds: Election of Directors. To elect nine director nominees numbered 01 through 09 to serve for a one-year term extending until the 2025 annual meeting of stockholders and their successors are duly elected and qualified: Marla Kessler
IRONWOOD PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Marla Kessler”): 130,081,722 for, 5,410,110 withheld, per its Form 8-K filed June 21, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The stockholders elected nine director nominees, each to serve on the board of directors of the Company for a one-year term extending until the 2024 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified, or until his or her death, resignation or removal, based …”
Support: 96% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 90 asset managers below reported 71,975,354 for, 61,510 withheld, 4,015 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 19,802,874 | 0 | 0 | 0 | For |
| BlackRock | 16,293,964 | 0 | 0 | 0 | For |
| State Street | 9,850,449 | 0 | 0 | 1,271 | For |
| Pacer Funds Trust | 7,393,012 | 0 | 0 | 0 | For |
| Fidelity | 3,523,928 | 0 | 0 | 0 | For |
| TIAA | 1,846,558 | 0 | 0 | 0 | For |
| Charles Schwab | 1,362,879 | 0 | 0 | 0 | For |
| GLENMEDE FUND INC | 1,066,522 | 0 | 0 | 0 | For |
| FIRST EAGLE FUNDS | 932,893 | 0 | 0 | 0 | For |
| Brown Capital Management Mutual Funds | 770,390 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 610,957 | 0 | 0 | 0 | For |
| Royce | 578,312 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 480,330 | 0 | 0 | 0 | For |
| NORTHERN LIGHTS FUND TRUST II | 400,000 | 0 | 0 | 0 | For |
| Principal | 378,739 | 0 | 0 | 0 | For |
| Equitable | 357,417 | 0 | 0 | 0 | For |
| Invesco | 352,644 | 0 | 0 | 0 | For |
| Nationwide | 350,718 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 339,705 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 300,000 | 0 | 0 | 0 | For |
| Jackson National | 297,949 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 295,089 | 0 | 0 | 0 | For |
| SEI | 281,994 | 0 | 0 | 0 | For |
| Putnam | 261,367 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 258,397 | 0 | 0 | 0 | For |
Showing the 25 largest of 90 asset managers. All 90 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Prior year: 98.7% for (June 20, 2023 meeting) ▼ 0.1 pts
Description as filed by funds: Election of Directors. To elect nine director nominees numbered 01 through 09 to serve for a one-year term extending until the 2025 annual meeting of stockholders and their successors are duly elected and qualified: Thomas McCourt
IRONWOOD PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Thomas McCourt”): 133,639,699 for, 1,852,133 withheld, per its Form 8-K filed June 21, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The stockholders elected nine director nominees, each to serve on the board of directors of the Company for a one-year term extending until the 2024 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified, or until his or her death, resignation or removal, based …”
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 90 asset managers below reported 71,975,354 for, 61,510 withheld, 4,015 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 19,802,874 | 0 | 0 | 0 | For |
| BlackRock | 16,293,964 | 0 | 0 | 0 | For |
| State Street | 9,850,449 | 0 | 0 | 1,271 | For |
| Pacer Funds Trust | 7,393,012 | 0 | 0 | 0 | For |
| Fidelity | 3,523,928 | 0 | 0 | 0 | For |
| TIAA | 1,846,558 | 0 | 0 | 0 | For |
| Charles Schwab | 1,362,879 | 0 | 0 | 0 | For |
| GLENMEDE FUND INC | 1,066,522 | 0 | 0 | 0 | For |
| FIRST EAGLE FUNDS | 932,893 | 0 | 0 | 0 | For |
| Brown Capital Management Mutual Funds | 770,390 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 610,957 | 0 | 0 | 0 | For |
| Royce | 578,312 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 480,330 | 0 | 0 | 0 | For |
| NORTHERN LIGHTS FUND TRUST II | 400,000 | 0 | 0 | 0 | For |
| Principal | 378,739 | 0 | 0 | 0 | For |
| Equitable | 357,417 | 0 | 0 | 0 | For |
| Invesco | 352,644 | 0 | 0 | 0 | For |
| Nationwide | 350,718 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 339,705 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 300,000 | 0 | 0 | 0 | For |
| Jackson National | 297,949 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 295,089 | 0 | 0 | 0 | For |
| SEI | 281,994 | 0 | 0 | 0 | For |
| Putnam | 261,367 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 258,397 | 0 | 0 | 0 | For |
Showing the 25 largest of 90 asset managers. All 90 are in the interactive database (link above).
Combines 14 wordings of this item as funds reported it.
94% Approved · of votes cast
Prior year: 98.2% for (June 20, 2023 meeting) ▼ 4.1 pts
Description as filed by funds: Approval, by non-binding advisory vote, of the compensation paid to the named executive officers.
IRONWOOD PHARMACEUTICALS INC.’s own tally for this item (“2. On a non-binding advisory basis, the compensation paid to the Company's named executive officers, as disclosed in the Company's proxy statement for the Annual Meeting, based on the following votes”): 127,439,687 for, 7,953,508 against — passed, per its Form 8-K filed June 21, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The stockholders approved, on a non-binding advisory basis, the compensation paid to the Company's named executive officers, as disclosed in the Company's proxy statement for the Annual Meeting, based on the following votes:”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 19,802,874 | 0 | 0 | 0 | For |
| BlackRock | 16,293,964 | 0 | 0 | 0 | For |
| State Street | 9,851,720 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 7,393,012 | 0 | 0 | 0 | For |
| Fidelity | 3,523,928 | 0 | 0 | 0 | For |
| TIAA | 1,846,558 | 0 | 0 | 0 | For |
| Charles Schwab | 1,362,879 | 0 | 0 | 0 | For |
| GLENMEDE FUND INC | 1,066,522 | 0 | 0 | 0 | For |
| FIRST EAGLE FUNDS | 932,893 | 0 | 0 | 0 | For |
| Brown Capital Management Mutual Funds | 0 | 770,390 | 0 | 0 | Against |
| Columbia Threadneedle | 0 | 610,957 | 0 | 0 | Against |
| Royce | 578,312 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 480,330 | 0 | 0 | 0 | For |
| World Funds Trust | 406,801 | 0 | 0 | 0 | For |
| NORTHERN LIGHTS FUND TRUST II | 400,000 | 0 | 0 | 0 | For |
| Principal | 378,739 | 0 | 0 | 0 | For |
| Two Roads Shared Trust | 363,047 | 0 | 0 | 0 | For |
| Equitable | 357,417 | 0 | 0 | 0 | For |
| Invesco | 352,644 | 0 | 0 | 0 | For |
| Nationwide | 215,382 | 135,336 | 0 | 0 | Mixed |
| FINANCIAL INVESTORS TRUST | 339,705 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 300,000 | 0 | 0 | 0 | For |
| Jackson National | 297,949 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 295,089 | 0 | 0 | 0 | For |
| SEI | 281,994 | 0 | 0 | 0 | For |
Fund voting reports, all 93 managers: 71,256,192 for, 1,563,921 against, 34,334 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| State Street | 12,591,997 | 0 | 0 | 0 | For |
| Man Group plc | 6,379,760 | 0 | 0 | 0 | For |
| ARMISTICE CAPITAL, LLC | 0 | 3,677,175 | 0 | 0 | Against |
| BlackRock | 3,638,342 | 0 | 0 | 0 | For |
| LSV ASSET MANAGEMENT | 3,346,397 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 3,102,697 | 0 | 0 | 0 | For |
| Renaissance | 2,750,288 | 0 | 0 | 0 | For |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 2,629,809 | 0 | 0 | 0 | For |
| JUPITER ASSET MANAGEMENT LTD | 1,978,009 | 0 | 0 | 0 | For |
| APG Asset Management US Inc. | 1,964,344 | 0 | 0 | 0 | For |
| Nuveen | 1,851,373 | 0 | 0 | 0 | For |
| BRAIDWELL LP | 1,543,682 | 0 | 0 | 0 | For |
| Kynam Capital Management, LP | 0 | 0 | 0 | 1,441,029 | Withhold |
| BROWN CAPITAL MANAGEMENT LLC | 0 | 1,418,332 | 0 | 0 | Against |
| Charles Schwab | 1,411,265 | 0 | 0 | 0 | For |
| Northern Trust | 1,298,795 | 94 | 0 | 0 | For |
| First Eagle Investment Management, LLC | 1,017,225 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 927,966 | 0 | 0 | 0 | For |
| Two Sigma | 919,312 | 0 | 0 | 0 | For |
| NEW YORK STATE COMMON RETIREMENT FUND | 809,002 | 0 | 0 | 0 | For |
| PRINCIPAL GLOBAL INVESTORS | 801,405 | 0 | 0 | 0 | For |
| Vanguard | 653,984 | 0 | 0 | 0 | For |
| EMERALD MUTUAL FUND ADVISERS TRUST | 644,153 | 0 | 0 | 0 | For |
| Saturn V Capital Management LP | 528,812 | 0 | 0 | 0 | For |
| Rafferty Asset Management, LLC | 480,330 | 0 | 0 | 0 | For |
Institutional-manager reports, all 216 managers: 60,849,895 for, 5,664,248 against, 1,441,029 withheld, 28,581 abstained, 2,989 not voted. Showing the 25 largest; every one is in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
96% Approved · of votes cast
Prior year: 97.3% for (June 20, 2023 meeting) ▼ 1.7 pts
Description as filed by funds: Ratification of the selection of Ernst & Young LLP as Ironwood Pharmaceuticals, Inc.'s independent registered public accounting firm for 2024.
IRONWOOD PHARMACEUTICALS INC.’s own tally for this item (“3. The selection of Ernst & Young LLP as the Company's independent registered public accounting firm for 2024, based on the following votes”): 136,781,986 for, 6,305,538 against — passed, per its Form 8-K filed June 21, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The stockholders ratified the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for 2024, based on the following votes:”
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 95 asset managers below reported 72,666,663 for, 153,922 against, 34,334 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 19,802,874 | 0 | 0 | 0 | For |
| BlackRock | 16,293,964 | 0 | 0 | 0 | For |
| State Street | 9,850,243 | 1,477 | 0 | 0 | For |
| Pacer Funds Trust | 7,393,012 | 0 | 0 | 0 | For |
| Fidelity | 3,523,928 | 0 | 0 | 0 | For |
| TIAA | 1,846,558 | 0 | 0 | 0 | For |
| Charles Schwab | 1,362,879 | 0 | 0 | 0 | For |
| GLENMEDE FUND INC | 1,066,522 | 0 | 0 | 0 | For |
| FIRST EAGLE FUNDS | 932,893 | 0 | 0 | 0 | For |
| Brown Capital Management Mutual Funds | 770,390 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 610,957 | 0 | 0 | 0 | For |
| Royce | 578,312 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 480,330 | 0 | 0 | 0 | For |
| World Funds Trust | 406,801 | 0 | 0 | 0 | For |
| NORTHERN LIGHTS FUND TRUST II | 400,000 | 0 | 0 | 0 | For |
| Principal | 378,739 | 0 | 0 | 0 | For |
| Two Roads Shared Trust | 363,047 | 0 | 0 | 0 | For |
| Equitable | 357,417 | 0 | 0 | 0 | For |
| Invesco | 352,644 | 0 | 0 | 0 | For |
| Nationwide | 350,718 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 339,705 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 300,000 | 0 | 0 | 0 | For |
| Jackson National | 297,949 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 295,089 | 0 | 0 | 0 | For |
| SEI | 281,994 | 0 | 0 | 0 | For |
Showing the 25 largest of 95 asset managers. All 95 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 158,957,123 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 12.46% |
| 2 | BlackRock | 10.25% |
| 3 | State Street | 6.20% |
| 4 | Pacer Funds Trust | 4.65% |
| 5 | Fidelity | 2.22% |
| 6 | TIAA | 1.16% |
| 7 | Charles Schwab | 0.86% |
| 8 | GLENMEDE FUND INC | 0.67% |
| 9 | FIRST EAGLE FUNDS | 0.59% |
| 10 | Brown Capital Management Mutual Funds | 0.48% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | State Street | 7.92% |
| 2 | Man Group plc | 4.01% |
| 3 | ARMISTICE CAPITAL, LLC | 2.31% |
| 4 | BlackRock | 2.29% |
| 5 | LSV ASSET MANAGEMENT | 2.11% |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 1.95% |
| 7 | Renaissance | 1.73% |
| 8 | JACOBS LEVY EQUITY MANAGEMENT, INC | 1.65% |
| 9 | JUPITER ASSET MANAGEMENT LTD | 1.24% |
| 10 | APG Asset Management US Inc. | 1.24% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| Alexander Denner, Ph.D. | 16,511,939 | 10.39% | Proxy statement (DEF 14A), proxy filed April 25, 2024 |
| Sarissa Capital Management LP | 16,390,000 | 10.31% | Proxy statement (DEF 14A), proxy filed April 25, 2024 |
| Vanguard Group | 16,072,006 | 10.11% | Form 13F, quarter ended March 31, 2024 |
| State Street | 13,917,111 | 8.76% | Form 13F, quarter ended March 31, 2024 |
| BlackRock | 12,062,558 | 7.59% | Form 13F, quarter ended March 31, 2024 |
| Renaissance Technologies | 7,099,801 | 4.47% | Form 13F, quarter ended March 31, 2024 |
| Geode Capital | 3,147,158 | 1.98% | Form 13F, quarter ended March 31, 2024 |
| Nuveen | 1,843,243 | 1.16% | Form 13F, quarter ended March 31, 2024 |
| Thomas McCourt | 1,621,326 | 1.02% | Proxy statement (DEF 14A), proxy filed April 25, 2024 |
| Citadel Advisors | 1,552,474 | 0.98% | Form 13F, quarter ended March 31, 2024 |
Percentages above are of 158,957,123 shares outstanding, as reported by IRONWOOD PHARMACEUTICALS INC. on its Form 10-Q dated March 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At IRONWOOD PHARMACEUTICALS INC.'s shareholder meeting held June 18, 2024, in the 2023-2024 proxy season, 286 asset managers reported votes on at least one of its 11 ballot items in their SEC Form N-PX filings, covering 3,329 separate fund positions. On the most widely held item on that ballot — Approval, by non-binding advisory vote, of the compensation paid to the named executive… — IRONWOOD PHARMACEUTICALS INC.'s filing reports the proposal as approved, with 94% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: IRONWOOD PHARMACEUTICALS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 21, 2024.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from IRONWOOD PHARMACEUTICALS INC.’s 10-Q dated March 31, 2024. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
IRONWOOD PHARMACEUTICALS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.
Proxy Votes Now, “IRONWOOD PHARMACEUTICALS (IRWD) 2024 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/ironwood-pharmaceuticals-inc/2024 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.